Ding, Youxiang
Xu, Yuting
Fu, Yao
Zhang, Heng
Zhao, Li
Fan, Xiangshan
Funding for this research was provided by:
Nanjing Medical Science and Technology Development Project (ZKX17013)
Article History
Received: 17 September 2022
Accepted: 31 October 2022
First Online: 6 November 2022
Declarations
:
: The collection of clinical sample slides complied with guidelines in the Declaration of Helsinki and was approved by The Institutional Ethical Committee of Nanjing Drum Tower Hospital (approval no. 2019-196-01). Informed consent form was obtained from each patient. The animal study was approved by the SPF Animal Laboratory of China Pharmaceutical University. For the xenograft tumor model, the largest tumor volume was about 1200 mm<sup>3</sup> which is smaller than 1500 mm<sup>3</sup> stipulated by the Animal Ethic Committee.
: The authors declare that there are no competing interests.